TOVX   $0.2495  0.40% Market Closed After Close 0.249 -0.20%

Theriva Biologics, Inc.
Total Cash 16.59M
totalCashPerShare 16.506
EBITDA -21.40M
Total Debt 1.83M
quickRatio 2.705
currentRatio 2.879
Total Revenue
debtToEquity 6.619
Revenue/Share
ROA -0.24976
ROE -0.59064
grossProfits
freeCashflow -14.63M
operatingCashflow -17.83M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -11.55M
forwardPE -0.10459459
floatShares 658.77K
sharesOutstanding 2.27M
sharesShort 79.01K
sharesShortPriorMonth 90.98K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.21%
Short Ratio help_outline 0.02%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 28.915
Price To Book help_outline 0.07
earningsQuarterlyGrowth
netIncomeToCommon -22.27M
trailingEps -31.25%
forwardEps -18.50%
enterpriseToEbitda 0.54
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 23
lastUpdated Nov. 1, 2024, 10:18 p.m.